Sangamo BioSciences | SGMO - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Sangamo BioSciences

Sangamo BioSciences reported $227.09M in Current Assets for its fiscal quarter ending in March of 2023.


Current Assets Change
Alaunos Therapeutics Inc ZIOP:US USD 38.18M 15.61M
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Amgen AMGN:US USD 44.7B 22.52B
Avrobio Inc AVRO:US USD 77.25M 22.71M
Bayer BAYN:GR EUR 39.62B 1.86B
Biogen BIIB:US USD 9.76B 28.7M
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
Bluebird Bio BLUE:US USD 351.07M 151.58M
Gilead Sciences GILD:US USD 14.37B 855M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Intercept Pharmaceuticals ICPT:US USD 490.46M 49.67M
Ionis Pharmaceuticals IONS:US USD 2.54B 339.92M
J&J JNJ:US USD 64.39B 9.09B
Karyopharm Therapeutics KPTI:US USD 318.54M 37.93M
Novartis NOVN:VX USD 32.11B 4.8B
Regulus Therapeutics RGLS:US USD 34.56M 9.52M
Roche Holding ROG:VX 33.82B 3.5B
Sangamo BioSciences SGMO:US USD 227.09M 73.24M
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Vertex Pharmaceuticals VRTX:US USD 12.97B 269.1M